Rare diseases
Investigational molecules
Locations
Back to Spain210 clinical trials in Donostia / San Sebastian, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson's Disease
SpainStudy of NMD670 tablets to improve muscle strength in adults with TYPE 3 spinal muscular atrophy who can walk
SpainTitle: Comparing Brentuximab Vedotin plus ESHAP versus ESHAP alone in treating patients with relapsed or refractory classical Hodgkin's Lymphoma
SpainStudy on Durvalumab, Olaparib, and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer in Spain
SpainStudy on Capivasertib and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer After Standard Treatment Progression
SpainStudy on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment
SpainStudy on the Effects of Dimethyl Fumarate for Patients with Adrenomyeloneuropathy
SpainStudy on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery
SpainStudy Comparing Polatuzumab Vedotin with Rituximab, Ifosfamide, Carboplatin, and Etoposide for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
SpainStudy of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery
SpainStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
SpainStudy on the Effectiveness of Durvalumab and Bevacizumab with TACE in Patients with Localized Liver Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Parkinson's disease and Alzheimer's disease, including studies of novel therapeutics and disease-modifying treatments.
Multiple trials investigating innovative approaches to manage disease progression and symptoms.
Comprehensive research into various cancer types, with emphasis on advanced colorectal cancer and melanoma treatments.
Focus on personalized treatment approaches and novel drug combinations.
Specialized research targeting Amyotrophic Lateral Sclerosis (ALS) and other rare conditions, exploring innovative therapeutic approaches.
Development of targeted therapies for challenging medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
